Literature DB >> 6149959

Role of calmodulin in neurotransmitter synthesis.

H Fujisawa, T Yamauchi, H Nakata, S Okuno.   

Abstract

Tyrosine 3-monooxygenase (EC 1.14.16.2) and tryptophan 5-monooxygenase (EC 1.14.16.4) are generally believed to be the rate-limiting enzymes in the biosynthesis of the neurotransmitters, catecholamines and serotonin, respectively, and therefore the regulation of their activities is of particular importance. At least three calmodulin-dependent protein kinases differed in their molecular weights and substrate specificities, designated I, II, and III in the order of decreasing molecular weight, in rat brain cytosol. Among them, calmodulin-dependent protein kinase II with a molecular weight of about 540,000 appeared to occur only in the nervous tissues. Kinase II was found, on the one hand, to phosphorylate tyrosine 3-monooxygenase and tryptophan 5-monooxygenase, leading to the activation of these monooxygenases in the presence of activator protein and, on the other hand, to phosphorylate tubulin and microtubule-associated protein 2, which results in disassembly of the microtubules that had been assembled. These results suggest the possibility that both the secretion and biosynthesis of monoamine neurotransmitters stimulated by Ca2+ influx in the nervous system may be regulated by calmodulin-dependent protein kinase II via the phosphorylation of microtubule proteins and the phosphorylation of the monooxygenases that are the rate-limiting enzymes in the biosynthesis of the neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149959

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  8 in total

1.  The phosphorylation of choline acetyltransferase.

Authors:  G Bruce; L B Hersh
Journal:  Neurochem Res       Date:  1989-07       Impact factor: 3.996

2.  Effect of septal kindling on glutamate binding and calcium/calmodulin-dependent phosphorylation in a postsynaptic density fraction isolated from rat cerebral cortex.

Authors:  K Wu; C Wasterlain; L Sachs; P Siekevitz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

3.  Calmodulin selectively modulates the guanylate cyclase activity by repressing the lipid phase separation temperature in the inner half of the bilayer of rat brain synaptosomal plasma membranes.

Authors:  L Kopeikina-Tsiboukidou; G Deliconstantinos
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

Review 4.  The role of cell calcium in current approaches to toxicology.

Authors:  J G Pounds
Journal:  Environ Health Perspect       Date:  1990-03       Impact factor: 9.031

Review 5.  Putative therapeutic applications of calmodulin antagonists.

Authors:  R Mannhold; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

6.  Calmodulin content in human central nervous system tumors.

Authors:  A J Bridges; A K Ho
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

7.  Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).

Authors:  E Barron; R J Marshall; M Martorana; E Winslow
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

8.  The interactome and spatial redistribution feature of Ca2+ receptor protein calmodulin reveals a novel role in invadopodia-mediated invasion.

Authors:  Tao Li; Li Yi; Long Hai; Haiwen Ma; Zhennan Tao; Chen Zhang; Iruni Roshanie Abeysekera; Kai Zhao; Yihan Yang; Wei Wang; Bo Liu; Shengping Yu; Luqing Tong; Peidong Liu; Meng Zhu; Bingcheng Ren; Yu Lin; Kai Zhang; Cheng Cheng; Yubao Huang; Xuejun Yang
Journal:  Cell Death Dis       Date:  2018-02-20       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.